Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Industrial

Qualcomm’s Strategic Expansion: Industrial Chips and Potential Intel Partnership

Andreas Sommer by Andreas Sommer
November 17, 2025
in Industrial, Mergers & Acquisitions, Semiconductors, Tech & Software
0
Qualcomm Stock
0
SHARES
98
VIEWS
Share on FacebookShare on Twitter

Qualcomm is pursuing a dual-path strategy that has captured market attention. Alongside the debut of its latest industrial processor family, evidence suggests the semiconductor leader may be forging an unexpected technological alliance with longtime rival Intel. This potential collaboration could significantly influence Qualcomm’s market position and future growth trajectory.

Reducing Reliance on TSMC

Recent job postings from both Qualcomm and Apple indicate serious interest in engineers with specialized knowledge of Intel’s advanced chip packaging technologies, specifically EMIB and Foveros. These recruitment efforts strongly suggest that both technology giants are actively exploring alternatives to TSMC, which currently dominates the contract chip manufacturing landscape.

For Intel, securing Qualcomm as a foundry client would represent a major victory in its multi-year campaign to establish itself as a viable manufacturing partner for other chip designers. The strategic implications are substantial: Qualcomm could diminish its significant dependence on TSMC, whose production capacity remains consistently overstretched. This potential partnership would simultaneously validate Intel’s foundry ambitions while providing Qualcomm with additional manufacturing options and strengthened negotiating leverage.

New Industrial-Grade Processor Platform

Qualcomm Technologies unveiled its Dragonwing IQ-X series on Monday, introducing a new line of processors engineered specifically for demanding industrial environments. At the core of these chips lies the Qualcomm Oryon™ CPU, manufactured using advanced 4-nanometer process technology.

Should investors sell immediately? Or is it worth buying Qualcomm?

The platform delivers scalable configurations ranging from 8 to 12 high-performance cores and achieves artificial intelligence processing capabilities of up to 45 TOPS. Nakul Duggal, a Qualcomm Technologies executive, characterized the offering as delivering “best-in-class performance for industrial PC applications.” These processors are designed to power machine interfaces, edge controllers, and industrial computing systems, representing a strategic push into global manufacturing facilities.

Broadening Business Foundations

The launch of the Dragonwing series underscores Qualcomm’s continued execution of its diversification strategy. While smartphone chips remain the company’s primary revenue source, the corporation is systematically expanding into emerging growth sectors including automotive technology and industrial IoT.

Market analysts maintain a “Moderate Buy” assessment of Qualcomm shares. Following the company’s strong quarterly report in early November, investor attention is now focused on market adoption of these new industrial processors and potential developments regarding the speculated collaboration with Intel. The combination of product expansion and potential manufacturing diversification could accelerate Qualcomm’s growth beyond its traditional mobile stronghold.

Ad

Qualcomm Stock: Buy or Sell?! New Qualcomm Analysis from February 7 delivers the answer:

The latest Qualcomm figures speak for themselves: Urgent action needed for Qualcomm investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Qualcomm: Buy or sell? Read more here...

Tags: Qualcomm
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
Walgreens Stock

Walgreens Implements Drastic Cost-Cutting Measures Under New Ownership

Robinhood Stock

Robinhood Shares Surge to Record Highs on Stellar Performance

Amazon Stock

Amazon's Potential Warner Bros Acquisition Faces Regulatory Scrutiny

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com